Citation
Select
Ciriello Computational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C,
Emerging landscape of oncogenic signatures across human cancers.
Nat Genet. 2013 Sep 26;45(10):1127-1133
Citation
Select
Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, CKD Prognosis Consortium CKD Prognosis Consortium
Cystatin C versus creatinine in determining risk based on kidney function
N Engl J Med. 2013 Sep 5;369(10):932-43
Citation
Select
Delewi R, Hirsch A, Tijssen JG, Schächinger V, Wojakowski W, Roncalli J, Aakhus S, Erbs S, Assmus B, Tendera M, Goekmen Turan R, Corti R, Henry T, Lemarchand P, Lunde K, Cao F, Huikuri HV, Sürder D, Simari RD, Janssens S, Wollert KC, Plewka M, Grajek S, Traverse JH, Zijlstra F, Piek JJ
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis
Eur Heart J. 2013 Sep 11. [Epub ahead of print]
Citation
Select
Soni NJ, Samson DJ, Galaydick JL, Vats V, Huang ES, Aronson N, Pitrak DL,
Procalcitonin-guided antibiotic therapy: A systematic review and meta-analysis.
J Hosp Med. 2013 Sep;8(9):530-40
Citation
Select
Thom S, Poulter N, Field J, Patel A, Prabhakaran D, Stanton A, Grobbee DE, Bots ML, Reddy KS, Cidambi R, Bompoint S, Billot L, Rodgers A; UMPIRE Collaborative Group
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial
JAMA. 2013 Sep 4;310(9):918-29